HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Leichter, S. B. Search for Related Content PubMed Articles by Leichter, S. B. Social Bookmarking                What's this?

Effects of the Medicare Modernization Act on Clinicians Involved in Diabetes Care

The first 20% of the full text of this article appears below.

	Introduction

 
Within the next few months, the federal government will implement the first major reorganization of the Medicare system for many years: the Medicare Prescription Drug Improvement and Modernization Act of 2003¹ (Table 1). The plan called "Medicare Part D" offers two major changes to the current system. First, it offers a pharmacy benefit to eligible seniors. An extensive discussion of this part of the Act may be found in a recent edition of the online Wall Street Journal.² The second and indirect effect of this reform may be to encourage the organization of Medicare recipients into managed care plans, which would function like other managed care plans.³ For seniors and other Medicare recipients who have diabetes, both aspects will substantially affect their health care. Those of us who render diabetes care to Medicare recipients should prospectively consider how these changes will affect our processes of care and plan accordingly.

	Medicare Part D: Pharmacy Benefit Plans

 
As Medicare Part D is implemented, eligible participants will be offered a variety of plans to cover the costs of prescription drugs. In many localities, the options may be varied and confusing.⁴ They may range from plans with low monthly premiums that provide partial or complete coverage for generic drugs only to plans with much higher premiums that will offer choices and . . . [Full Text of this Article]

	Implications for Medicare Beneficiaries and Providers

 

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. B. Leichter, N. Gingrich, L. Linn, B. Butler, and S. Griggs The Columbus Program: Building a Community Model of a 21st Century Intelligent Health System Clin. Diabetes, October 1, 2006; 24(4): 149 - 152. [Abstract] [Full Text] [PDF]

				S. B. Leichter Evaluating The Therapeutic Package for Diabetic Patients: The Whole Exceeds the Sum of Its Parts Clin. Diabetes, July 1, 2006; 24(3): 102 - 104. [Full Text] [PDF]